Skip to main content

Table 1 Overview of demographic data

From: Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures

Sex: Women 95 (42.6%) Men 128 (57.4%)
Number of seizures: 181 with single GTCS (81.2%) 42 with seizure series (18.8%)
Age: Mean 45 ± 19.2 years Median 44 years range 13–75 years
Vascular risk factors: None: 161 (72.2%) One: 50 (22.4%) Multiple: 12 (5.3%)
Seizure history: 1st seizure: 22 (9.9%) Known Epilepsy: 196 (87.9%) Substance withdrawal seizure: 5 (2.2%) (4 alcohol, 1 benzodiazepines)
Duration of epilepsy: Mean 13.1 ± 7 years Median 7 years range 0–64 years
No. of current AED: Mean 1.17 ± 1 AED Median 1 AED 0–6 AED
Length of stay: Mean 4.6 ± 3 days Median 4.9 days 0–35 days
Discharge or transfer to: Home: 214 (96%) Dept. Medicine: 5 (2.2%) Dept. Psychiatry: (1.8%)
Epileptogenic zone: unclassified: 124 (55.6%) Temporal: 38 (17%) Generalized: 23 (10.3%)
Frontal: 9 (4%) Occipital 1 (0.4%) Parietal: 1 (0.4%)
Multifocal: 19 (8.5%) Hemispheric: 5 (2.2%) Other: 2 (0.9%)
Seizure types: GTCS only: 125 (56.1%) GTCS and absence: 16 (6.8%) GTCS and myoclonus: 4 (1.8%)
GTCS and SPS: 12 (5.3%) GTCS, SPS and CPS: 64 (28.7%) LGS (GTCS, TS, CPS): 2 (0.9%)
Etiology: Unknown: 127 (57%) Idiopathic/genetic: 16 (7.2%) Hippocampal Sclerosis: 12 (5.4%)
Perinatal brain damage: 11 (4.9%) Posttraumatic: 9 (4%) Vascular malformation: 9 (4%)
Postischemic: 7 (3.1%) Postinfectious: 5 (2.2%) Other lesions: 4 (1.8%)
Unspecific lesion: 4 (1.8%) Cortical malformation: 5 (2.2%) Neoplastic: 3 (1.3%)
Posthemorrhagic: 2 (0.9%) Lennox Gastaut Syndrome: 2 (0.9%) Immune mediated: 1 (0.4%)
seizure frequency: GTCS Persistent (>1 in 6 months): 57 (25.3%)
Rare (< 1 in 6 months): 112 (49.8%)
Undefined: 54 (24.2%)
Other seizure types Daily: 11 (4.9%)
Persistent (>1 in 6 months): 27 (12.1%)
Rare (< 1 in 6 months): 130 (58.3%)
Undefined: 54 (24.2%)
Preexisting conditions All cardiovascular risk factors 62 / 223 (27.8%) Cardiovascular conditions (CAD, structural heart disease, arrhythmia, history of stroke, peripheral vascular disease): 58 /223 (26%)